The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125463001 12546300 1 I 20140512 20160704 20160711 20160711 EXP PHJP2016JP019003 NOVARTIS 73.00 YR M Y 0.00000 20160711 CN JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125463001 12546300 1 PS COMTAN ENTACAPONE 1 Oral 100 MG, TID 20796 100 MG TABLET TID
125463001 12546300 2 SS ROTIGOTINE ROTIGOTINE 1 Transdermal 2.25 MG, QD 808 MG 0 2.25 MG TAPE (INCLUDING POULTICE) QD
125463001 12546300 3 SS ROTIGOTINE ROTIGOTINE 1 Transdermal 4.5 MG, QD 808 MG 0 4.5 MG TAPE (INCLUDING POULTICE) QD
125463001 12546300 4 SS ROTIGOTINE ROTIGOTINE 1 Transdermal 9 MG, QD 808 MG 0 9 MG TAPE (INCLUDING POULTICE) QD
125463001 12546300 5 SS ROTIGOTINE ROTIGOTINE 1 Transdermal 13.5 MG, QD 808 MG 0 13.5 MG TAPE (INCLUDING POULTICE) QD
125463001 12546300 6 SS ROTIGOTINE ROTIGOTINE 1 Transdermal 18 MG, QD 808 MG 0 18 MG TAPE (INCLUDING POULTICE) QD
125463001 12546300 7 SS ROTIGOTINE ROTIGOTINE 1 Transdermal 22.5 MG, QD 808 MG 0 22.5 MG TAPE (INCLUDING POULTICE) QD
125463001 12546300 8 SS MENESIT CARBIDOPALEVODOPA 1 Oral 150 MG, QID 0 150 MG TABLET QID
125463001 12546300 9 SS REQUIP ROPINIROLE HYDROCHLORIDE 1 Oral 16 MG, QD Y 0 16 MG MODIFIED RELEASE TABLET QD
125463001 12546300 10 SS REQUIP ROPINIROLE HYDROCHLORIDE 1 Oral 4 MG, BID Y 0 4 MG MODIFIED RELEASE TABLET BID
125463001 12546300 11 SS MIRAPEX PRAMIPEXOLE DIHYDROCHLORIDE 1 Oral 4.5 MG, QD 0 4.5 MG EXTENDED RELEASE TABLET QD
125463001 12546300 12 SS MIRAPEX PRAMIPEXOLE DIHYDROCHLORIDE 1 Oral 0.75 MG, BID 0 .75 MG EXTENDED RELEASE TABLET BID
125463001 12546300 13 SS MIRAPEX PRAMIPEXOLE DIHYDROCHLORIDE 1 Oral 0.75 MG, BID 0 .75 MG EXTENDED RELEASE TABLET BID
125463001 12546300 14 SS FP-OD SELEGILINE HYDROCHLORIDE 1 Oral 2.5 MG, QD 0 2.5 MG TABLET QD
125463001 12546300 15 SS NOURIAST ISTRADEFYLLINE 1 Oral 20 MG, QD 0 20 MG TABLET QD
125463001 12546300 16 SS TRERIEF ZONISAMIDE 1 Oral 50 MG, QD 0 50 MG TABLET QD
125463001 12546300 17 C GANATON ITOPRIDE 1 Unknown UNK 0 TABLET
125463001 12546300 18 C METHYCOOL METHYLCOBALAMIN 1 Unknown UNK 0 TABLET
125463001 12546300 19 C AMLODIPINE BESILATE AMLODIPINE BESYLATE 1 Unknown UNK 0 TABLET
125463001 12546300 20 C MICARDIS TELMISARTAN 1 Unknown UNK 0 TABLET
125463001 12546300 21 C FAMOTIDINE. FAMOTIDINE 1 Unknown UNK 0 TABLET
125463001 12546300 22 C MAGMITT MAGNESIUM OXIDE 1 Unknown UNK 0 TABLET
125463001 12546300 23 C BROTIZOLAM BROTIZOLAM 1 Unknown UNK Y 0 TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125463001 12546300 1 Parkinson's disease
125463001 12546300 2 Parkinson's disease
125463001 12546300 8 Parkinson's disease
125463001 12546300 9 Parkinson's disease
125463001 12546300 11 Parkinson's disease
125463001 12546300 14 Parkinson's disease
125463001 12546300 15 Parkinson's disease
125463001 12546300 16 Parkinson's disease
125463001 12546300 17 Product used for unknown indication
125463001 12546300 18 Product used for unknown indication
125463001 12546300 19 Hypertension
125463001 12546300 20 Hypertension
125463001 12546300 21 Product used for unknown indication
125463001 12546300 22 Product used for unknown indication
125463001 12546300 23 Insomnia

Outcome of event

Event ID CASEID OUTC COD
125463001 12546300 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125463001 12546300 Application site erythema
125463001 12546300 Application site pruritus
125463001 12546300 Benign prostatic hyperplasia
125463001 12546300 Dyskinesia
125463001 12546300 Insomnia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125463001 12546300 2 20140217 20140303 0
125463001 12546300 3 20140304 20140331 0
125463001 12546300 4 20140401 20140414 0
125463001 12546300 5 20140415 20140512 0
125463001 12546300 6 20140513 20141226 0
125463001 12546300 7 20141227 0
125463001 12546300 9 20141118 0
125463001 12546300 10 20141119 0
125463001 12546300 11 20140526 0
125463001 12546300 12 20140527 20141118 0
125463001 12546300 13 20141119 0
125463001 12546300 15 20130710 0
125463001 12546300 16 20140428 0
125463001 12546300 20 20131128 0
125463001 12546300 22 20131106 0
125463001 12546300 23 20140525 0